Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia
- PMID: 12203164
- DOI: 10.1086/342064
Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia
Abstract
A risk prediction model for invasive bacterial infection (IBI) was prospectively evaluated among children presenting with cancer, fever, and neutropenia. The model incorporated assessment of 5 previously identified risk factors: serum level of C-reactive protein (CRP) >/=90 mg/L, hypotension, identification of relapse of leukemia as the cancer type, platelet count of </=50,000 platelets/mm(3), and recent receipt of chemotherapy [16]. Children were uniformly evaluated at enrollment and were classified as having high or low risk for IBI according to a model that considers the number and type of variables present. Of the 263 febrile episodes evaluated during a 17-month period, 140 (53%) were in IBI-positive children. The sensitivity, specificity, and positive and negative predictive values of the model were 92%, 76%, 82%, and 90%, respectively. Identification of these 5 risk factors during the first 24 h of hospitalization was helpful in discriminating between children with a high or low risk for IBI.
Similar articles
-
[Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].Rev Med Chil. 2001 Dec;129(12):1449-54. Rev Med Chil. 2001. PMID: 12080883 Review. Spanish.
-
Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.J Clin Oncol. 2004 Sep 15;22(18):3784-9. doi: 10.1200/JCO.2004.01.078. J Clin Oncol. 2004. PMID: 15365075 Clinical Trial.
-
The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.J Pediatr Hematol Oncol. 2007 Mar;29(3):131-6. doi: 10.1097/MPH.0b013e3180308770. J Pediatr Hematol Oncol. 2007. PMID: 17356388 Clinical Trial.
-
Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.J Clin Oncol. 2005 Oct 20;23(30):7437-44. doi: 10.1200/JCO.2004.00.5264. J Clin Oncol. 2005. PMID: 16234511
-
Evolving concepts of management of febrile neutropenia in children with cancer.Med Pediatr Oncol. 2002 Aug;39(2):77-85. doi: 10.1002/mpo.10073. Med Pediatr Oncol. 2002. PMID: 12116054 Review.
Cited by
-
The Impact of Interactive Video Games Training on the Quality of Life of Children Treated for Leukemia.Cancers (Basel). 2024 Oct 25;16(21):3599. doi: 10.3390/cancers16213599. Cancers (Basel). 2024. PMID: 39518038 Free PMC article.
-
Optimum management of pediatric patients with fever and neutropenia.Indian J Pediatr. 2004 Sep;71(9):825-35. doi: 10.1007/BF02730723. Indian J Pediatr. 2004. PMID: 15448391 Review.
-
Outpatient management of febrile neutropenia in children with cancer.Pediatr Rep. 2011 Feb 24;3(1):e8. doi: 10.4081/pr.2011.e8. Pediatr Rep. 2011. PMID: 21647281 Free PMC article.
-
Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.Pediatr Blood Cancer. 2015 Feb;62(2):262-268. doi: 10.1002/pbc.25275. Epub 2014 Oct 18. Pediatr Blood Cancer. 2015. PMID: 25327666 Free PMC article.
-
Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.Eur J Cancer. 2010 Nov;46(16):2950-64. doi: 10.1016/j.ejca.2010.05.024. Eur J Cancer. 2010. PMID: 20621468 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous